You are here

Braeburn Pharmaceuticals

FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder

Fierce Pharma

Wed, 05/24/23 - 06:38 pm

Braeburn Pharmaceuticals

opioid use disorder

FDA to reconsider Braeburn’s opioid addiction drug after court ruling

Pharmaforum

Wed, 07/24/19 - 10:15 pm

opioid addiction

Braeburn Pharmaceuticals

Drugmaker Petitions FDA to Revoke Sublocade Orphan Designation

RAPS.org

Thu, 04/11/19 - 10:09 am

Braeburn Pharmaceuticals

citizen petitions

BioCentury - ‘Tentative’ FDA approval for Braeburn's opioid addiction product

BioCentury

Wed, 12/26/18 - 04:44 pm

Braeburn Pharmaceuticals

Brixadi buprenorphine

opioid addiction

First Implant to Treat Opioid Addiction Gets FDA Approval

Bloomberg

Thu, 05/26/16 - 07:47 pm

opioid addiction

Braeburn Pharmaceuticals

Titan Pharmaceuticals

Titan Pharma Opioid Addiction Implant Passes Key Study Hurdle

TheStreet.com

Mon, 06/8/15 - 09:45 am

Titan Pharmaceuticals

opioid addiction

Braeburn Pharmaceuticals

Titan Pharma Gets Solidified Commitment From Braeburn To Probuphine

Seeking Alpha

Mon, 11/18/13 - 11:29 am

Titan Pharmaceuticals

Braeburn Pharmaceuticals